期刊文献+

人Kin17蛋白的原核表达及纯化 被引量:2

Prokaryotic Expression and Purification of Human Kin17 Protein
原文传递
导出
摘要 目的:构建重组质粒,在原核系统中表达带His标签的人Kin17融合蛋白,并对表达产物进行纯化及鉴定。方法:以PK3质粒为模板,PCR扩增出全长的KIN17基因,并将PCR产物插入到原核表达载体pET32a中,构建的重组质粒经BamHⅠ/HindⅢ双酶切及DNA测序方法鉴定正确后,转化至大肠杆菌BL21,并用丙基-β-硫代半乳糖苷诱导表达His-Kin17融合蛋白,最后应用Ni-NTA柱亲和层析方法来纯化融合蛋白及经Western免疫印迹鉴定纯化的重组蛋白。结果:双酶切及DNA测序方法证实pET32a-KIN17质粒构建正确,融合蛋白经诱导表达、纯化、鉴定后,得到纯度达到95%以上的His-Kin17重组蛋白。结论:成功构建携带KIN17基因的重组载体,并获得了高纯度的His-Kin17重组蛋白,为深入研究Kin17蛋白的分子结构、功能及其在肿瘤发生发展中的作用奠定了基础。 Objective: To express and purify the human Kinl7 fusion protein with His label by constructing recombinant plasmid in E. coll. Method:AU length of K/N17 gene was amplified from PK3 plasmid by PCR. And the PCR product was cloned into Prokaryotic vec- tor pET32a. After determined by double digestion and DNA sequencing, the recombinant plasmid pET32a - KIN17 was transformed into the prokaryotic expression cells BL21. Kinl7 protein induced with isopropy - β- D -thiogalaetoside (IPTG) in E. coli was purified on Ni -NTA resin column and determined by SDS- PAGE method and Western blot assay. Result:The recombinant plasmid pET32a- KIN17 carrying K/N17 gene was successfully constructed according to double digestion and DNA sequencing. After induction, purification and i- dentification, the purity of Kin17 fusion protein acquired was above 95 %. Conclusion:The recombinant plasmid pET32a - KIN17 carrying human K/N17 gene is constructed successfuUy, and the Kin17 recombinant protein with high purity was obtained in E. coli. This work will lay the foundation for the deep - going study of the molecular structure, function of Kin17 protein and its roles in the cancer development.
出处 《生物技术》 CAS CSCD 北大核心 2013年第3期28-31,共4页 Biotechnology
基金 国家自然科学基金项目("Kin17在非小细胞肺癌中的表达 作用及分子机制研究" 81201831) 广东省自然科学基金博士启动项目("Kin17对乳腺癌细胞致瘤性的影响及其分子机制研究" S2012040006310) 广东省医学科研基金项目("Kin17在肺癌中的表达及其与患者预后关系的研究" B2012266) 广东医学院科研基金项目("Kin17在肺癌中的表达 作用及其分子机制研究" B2011021)资助
关键词 Kin17蛋白 载体克隆 原核表达 纯化 鉴定 Kin17 protein Cloning vector Prokaryotic expression Purification Identification
  • 相关文献

参考文献11

  • 1Jemal A, Bray F,Center MM,et al. Global cancer statistics [ J ]. CACancer J Clin, 2011,61(2) :69 -90.
  • 2Lu J,Steeg PS,Price JE,et al. Breast cancer metastasis: challengesand opportunities [ J]. Cancer Res, 2009, 69( 12) :4951 -4953.
  • 3Yi EH, Lee CS, Lee JK, et al. STAT3 - RANTES autocrine signalingis essential for tamoxifen resistance in human breast cancer cellsCancer Res, 2013’ 11(1) :31 -42.
  • 4ZengT, Gao H, Yu P, et al. Up - regulation of kinl7 is essential forproliferation of breast cancer [ J]. PLoS One, 2011 , 6(9) :e25343.
  • 5Kannouche P,Mauffrey P,Pinon - Lataillade G,et al. Molecular clo-ning and characterization of the human KIN 17 cDNA encoding a componentof the UVC response that is conserved among metazoans [ J]- Carcinogene-sis, 2000,21(9) :1701 -1710.
  • 6Nunes - Xavier CE,Elson A,Pulido R. Epidermal growth factor recep-tor (EGFR) - mediated positive feedback of protein - tyrosine phosphataseepsilon ( PTPepsilon ) on ERK1/2 and AKT protein pathways is required forsurvival of human breast cancer cells [ J] ? J Biol Chem,2012, 287 (5 ):3433 -3444.
  • 7PeuralaE, Koivunen P, Haapasaari KM, et al. The prognostic signifi-cance and value of cyclin D1,CDK4 and pl6 in human breast cancer [ J].Breast Cancer Res, 2013,15( 1) :R5.
  • 8Xu J , Reumers J, Couceiro JR, et al. Gain of function of mutant p53by coaggregation with multiple tumor suppressors [J]. Nat Chem Biol,2011,7(5) :285 -295.
  • 9Pinon - lataillade G, Masson C,Bernardino - Sgherri J, et al. KIN 17encodes an RNA - binding protein and is expressed during mouse spermato-genesis [J]. J Cell Sci, 2004, U7(Pt 16) :3691 -3702.
  • 10le Maire A, Schiltz M, Stura EA,et al. A tandem of SH3 - like do-mains participates in RNA binding in KIN17 , a human protein activated inresponse to genotoxics [J]- J Mol Biol, 2006,364(4) :764 -776.

同被引文献19

  • 1Siegel RL,Miller KD,Jemal A.Cancer statistics,2016[J].CA:A Cancer Journal for Clinicians,2016,66(1):7-30.
  • 2Kos Z,Dabbs DJ.Biomarker assessment and molecular testing for prognostication in breast cancer[J].Histopathology,2016,68(1):70-85.
  • 3Almstedt K,Schmidt M.Targeted therapies overcoming endocrine resistance in hormone receptor-positive breast cancer[J].Breast Care,2015,10(3):168-172.
  • 4Zanardi E,Bregni G,de Braud F,et al.Better together:targeted combination therapies in breast cancer[J].Seminars in Oncology,2015,42(6):887-895.
  • 5Collignon J,Lousberg L,Schroeder H,et al.Triplenegative breast cancer:treatment challenges and solutions[J].Breast Cancer(Dove Med Press),2016,8:93-107.
  • 6Biard DS,Miccoli L,Despras E,et al.Participation of kin17 protein in replication factories and in other DNA transactions mediated by high molecular weight nuclear complexes[J].Molecular Cancer Research,2003,1(7):519-531.
  • 7Kannouche P,Pinon-Lataillade G,Tissier A,et al.The nuclear concentration of kin17,a mouse protein that binds to curved DNA,increases during cell proliferation and after UV irradiation[J].Carcinogenesis,1998,19(5):781-789.
  • 8Kou WZ,Xu SL,Wang Y,et al.Expression of Kin17 promotes the proliferation of hepatocellular carcinoma cells in vitro and in vivo[J].Oncology Letters,2014,8(3):1190-1194.
  • 9Yu M,Zhang Z,Yu H,et al.KIN enhances stem celllike properties to promote chemoresistance in colorectal carcinoma[J].Biochemical and Biophysical Research Communications,2014,448(1):63-69.
  • 10Ramos A,Gaspar V,Kelmer S,et al.The kin17 protein in murine melanoma cells[J].International Journal of Molecular Sciences,2015,16(12):27912-27920.

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部